Quick Answer
Sanara MedTech Inc. reported Research And Development Expense of $5.07 million for the year ending 2025.
- Sanara MedTech Inc. showed an increase of +79.3% in Research And Development Expense from 2024 to 2025.
- This data is from Sanara MedTech Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $4.4 thousand | Q2 2020: $41.5 thousand | Q3 2020: $11.0 thousand | Q1 2021: $118.2 thousand | Q2 2021: $104.0 thousand | Q3 2021: $35.7 thousand | Q1 2022: $204.6 thousand | Q2 2022: $1.07 million | Q3 2022: $1.06 million | Q1 2023: $1.32 million | Q2 2023: $1.18 million | Q3 2023: $986.5 thousand | Q1 2024: $946.3 thousand | Q2 2024: $985.7 thousand | Q3 2024: $783.8 thousand | Q1 2025: $1.11 million | Q2 2025: $1.26 million | Q3 2025: $1.03 million.
- Over the full 6 years of available data (2020 to 2025), Sanara MedTech Inc.'s Research And Development Expense has grown by 12,521.3%.
- Historical annual values: Fiscal year 2025: $5.07 million | Fiscal year 2024: $2.83 million | Fiscal year 2023: $4.13 million | Fiscal year 2022: $3.37 million | Fiscal year 2021: $558.7 thousand | Fiscal year 2020: $40.2 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: